Zuckerberg Trying to Simulate Human Biology at the Cellular Level
Mark Zuckerberg's Chan Zuckerberg Biohub is investing $500 million in AI models of human cells to accelerate disease cure and prevention. The five-year plan aims to create predictive models of human cells to help medical researchers understand cellular interactions.
Mark Zuckerberg's Chan Zuckerberg Biohub is investing $500 million in AI models of human cells. The foundation's goal is to 'cure and prevent all disease through AI-powered biology, frontier research, and state-of-the-art technology.' The five-year plan will create predictive models of human cells to help medical researchers understand cellular interactions. $400 million will go to Biohub's AI development, and the rest will fund third-party researchers. The project aims to unlock advancements in bioscience and potentially eradicate deadly diseases. The investment comes as Meta paid a low federal income tax rate of 3.5% in 2025 despite having its best year ever, bringing in $79 billion in profits.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.